Immune Monitoring & Cancer Omics Labs

Advanced Assay Services for Translational Cancer Research

Supporting academic, biotech, and pharmaceutical partners with immune profiling, spatial biology, proteomics, and genomic assay services that deliver translational, decision-ready data — backed by the Knight Cancer Institute's research infrastructure.

Representative multi‑parameter assay data visualization

Expert Scientific Team

PhD-level immunologists and pathologists guiding every study.

Translational Research Focus

Assay outputs designed to bridge bench discovery and clinical application, across every service line.

Multi-Platform Capabilities

Spatial imaging, proteomics, and sequencing under one roof.

Collaborative Study Design

Direct scientist access from protocol through data interpretation.

Our Origin

The Science Behind IMCO

Launched by the OHSU Knight Cancer Institute in 2020, IMCO was built to give clinical, translational, and basic researchers a single, integrated home for translational assay services — spanning immune profiling, spatial biology, proteomics, and genomics — from sample to signal.

CLINICAL & TRANSLATIONAL

Comprehensive Analytical Support

An integrated infrastructure of cutting-edge assays and advanced analytics — spanning immune profiling, spatial biology, proteomics, and genomics — uncovers mechanisms of resistance and develops predictive biomarkers for therapeutic response, risk stratification, and toxicity.

BASIC SCIENCE

Built for Discovery

Researchers get direct access to state-of-the-art platforms and high-dimensional analysis — accelerating discovery and enabling innovative, hypothesis-driven projects.

INFRASTRUCTURE

One Centralized Laboratory

Built to consolidate and streamline studies involving human biospecimens, IMCO delivers scalable, GLP-aligned, CLIA-compliant research assays grounded in foundational science.

What We Do

Comprehensive translational assay services

An integrated infrastructure of cutting-edge assays and advanced analytics — immune profiling, spatial biology, proteomics, and genomics — built to deliver translational, decision-ready data at every stage of your study.

Research Analytics

Custom bioinformatics and biostatistics support across every assay platform in our portfolio.

Learn More

CycIF & Spatial Biology

Cyclic immunofluorescence for high-plex, single-cell spatial characterization.

Learn More

Digital Spatial Pathology — NanoString GeoMx

Spatially resolved profiling of RNA and protein within tissue context.

Learn More

Olink Proteomics

Certified Olink service provider for high-throughput protein biomarker discovery.

Learn More

Multiplex IHC

Simultaneous detection of multiple markers within tissue architecture.

Learn More

CyTOF — Mass Cytometry

High-dimensional, single-cell immune profiling across dozens of parameters.

Learn More

Whole Exome Sequencing & RNA-Seq

Genomic and transcriptomic profiling to inform biomarker discovery.

Learn More

Histopathology Shared Resource

Full tissue processing, sectioning, and staining support for research studies.

Learn More
Why IMCO

A boutique partner with big-lab capability

EXPERTISE

Scientific Expertise

Researchers with deep immunology experience guide study design and interpretation, not just sample processing.

PARTNERSHIP

Collaborative Partnership

Direct access to the scientists running your assays — no account-manager layer between you and the lab bench.

SUPPORT

End-to-End Support

From protocol design through data delivery and interpretation, IMCO stays engaged at every stage.

By the Numbers

IMCO metrics & impact

25+
Clinical Trials Supported
10,000+
Samples Processed
98%
On-Time Sample Turnaround
6
Years Delivering Translational Assay Services

Ready to accelerate your research?

Tell us about your study — our scientific team will help scope the right combination of assays and analytics.